Abrocitinib Treatment for Localized Type of Generalized Pustular Psoriasis: A Case Report

Zhili Yang, Jiejie Lu, Zhen Li Department of Dermatology, The Fifth People’s Hospital of Hainan Province, Haikou, Hainan, People’s Republic of ChinaCorrespondence: Zhen Li, Email nanji9207@163.com Jiejie Lu, Email lujiejie677@163.comAbstract: Generalized Pustular Psoriasis (GPP) is a recurrent derma...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Z, Lu J, Li Z
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
Online Access:https://www.dovepress.com/abrocitinib-treatment-for-localized-type-of-generalized-pustular-psori-peer-reviewed-fulltext-article-CCID
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Zhili Yang, Jiejie Lu, Zhen Li Department of Dermatology, The Fifth People’s Hospital of Hainan Province, Haikou, Hainan, People’s Republic of ChinaCorrespondence: Zhen Li, Email nanji9207@163.com Jiejie Lu, Email lujiejie677@163.comAbstract: Generalized Pustular Psoriasis (GPP) is a recurrent dermatological condition characterized by widespread erythematous plaques, scaling, and sterile pustules. Notably, in a subset of patients, these lesions manifest exclusively in localized areas. We report a case where abrocitinib was used to treat the localized type of GPP, achieving relatively good clinical efficacy and without obvious side effects. To date, there are no published reports on the use of abrocitinib for GPP treatment, either domestically or internationally, making this case a valuable reference for clinicians and researchers.Keywords: generalized pustular psoriasis, abrocitinib, JAK inhibitor
ISSN:1178-7015